Evidence map›Paper›PMID 21873523›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

An age-specific CD8+ T cell pathway that impairs the effectiveness of strategies to prolong allograft survival.

Wei Du, Hua Shen, Anjela Galan, Daniel R Goldstein

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Clonally expanded memory CD8Nature aging · 2023
    Article
  4. Aging and the immune response to organ transplantation.The Journal of clinical investigation · 2017
    Review
  5. Article
  6. Immunosenescence and organ transplantation.Transplantation reviews (Orlando, Fla.) · 2013
    Review
  7. Article
  8. Review
  9. Solid-organ transplantation in older adults: current status and future research.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wei DuDepartment of Internal Medicine and Immunobiology, Yale University School of Medicine, New Haven, CT 06525, USA.
Hua Shen
Anjela Galan
Daniel R Goldstein

Funding

Mechanisms to augment primary immunity in agingR01AG028082 · NIA · YALE UNIVERSITY · PI DENG, JANE C · 2007 to 2023
$6.9M
Role of Innate Immunity in Transplantation ToleranceR01AI064660 · NIAID · YALE UNIVERSITY · PI GOLDSTEIN, DANIEL ROBERT · 2006 to 2010
$1.7M
Aging, Viral Immunity and AtherosclerosisK02AG033049 · NIA · YALE UNIVERSITY · PI GOLDSTEIN, DANIEL ROBERT · 2008 to 2012
$737k
The Role of Innate Immunity in Transplant ToleranceR56AI064660 · NIAID · YALE UNIVERSITY · PI GOLDSTEIN, DANIEL ROBERT · 2011 to 2011
$187k
NIAID NIH HHS AI064660NIAID NIH HHS R01 AI064660NIAID NIH HHS R56 AI064660NIA NIH HHS AG028082NIA NIH HHS AG033049NIA NIH HHS K02 AG033049NIA NIH HHS R01 AG028082
6 · The paper itself

Abstract

Age-related decline in immunity can impair cell-mediated responses during an infection, malignancy, and acute allograft rejection. Although much research has been allocated to understand the immune responses that impact the former two conditions, the cellular mechanisms by which aging impacts the immune acceptance of organ allografts are not completely clear. In this study, we examined how recipient age impacts the efficacy of therapies that modulate immune recognition of allografts using an immunogenic murine skin transplant model. We found that costimulatory blockade-based treatment failed to extend allograft survival in older recipients to the same extent as that observed in younger recipients. CD8(+) T cells were critical for the inability of aged recipients to achieve maximal allograft survival. Although aged mice displayed a larger number of effector memory T cells prior to transplantation, these cells did not exhibit enhanced alloreactivity compared with young memory T cells. In contrast, naive aged CD8(+) T cells exhibited enhanced IFN-γ production to allostimulation compared with young naive T cells. Our results provide evidence that aging enhances CD8(+) T cell alloreactivity. This could impair the ability of costimulatory blockade-based therapies to prolong allograft survival. Thus, targeting CD8(+) T cells in humans may be a way to improve outcomes in older patients requiring immune modulatory therapy.

Indexed as

AgingAnimalsCD8-Positive T-LymphocytesCell SeparationEnzyme-Linked Immunosorbent AssayFlow CytometryGraft RejectionGraft SurvivalMiceMice, Inbred C57BLMice, Inbred CBASkin TransplantationTransplantation, Homologous

Identifiers

PMID21873523
PMCPMC3178732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.